September 2025—Bio-Rad Laboratories has launched four Droplet Digital PCR platforms, which include the company’s QX Continuum ddPCR system and the QX700 series of ddPCR platforms, acquired as part of Bio-Rad’s recent purchase of Stilla Technologies.
The QX Continuum ddPCR system is designed for translational research applications and features a qPCR-like workflow, four-color multiplexing, and up to eight discrete thermal profiles per plate. The QX700 series consists of three ddPCR instruments designed for academic research, environmental testing, cell and gene therapy, and biopharma quality control workflows. The systems enable seven-color multiplexing, can process more than 700 samples per day, and include easy-to-use software for streamlined data interpretation.
Bio-Rad Laboratories, 510-724-7000